Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EVALUATION OF THE EFFICACY OF AN ANTIMELANOGENESIS AGENT (MELASYL) IN DIFFERENT CONCENTRATIONS UNDER PART OF VISIBLE LIGHT [400-450NM] EXPOSURES AND UNDER FULL VISIBLE LIGHT [400-700NM] EXPOSURES

NCT06937515 is registered in ClinicalTrials.gov with L'Oreal as lead sponsor.

NCT NCT06937515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06937515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EVALUATION OF THE EFFICACY OF AN ANTIMELANOGENESIS AGENT (MELASYL) IN DIFFERENT CONCENTRATIONS UNDER PART OF VISIBLE LIGHT [400-450NM] EXPOSURES AND UNDER FULL VISIBLE LIGHT [400-700NM] EXPOSURES
Lead sponsor
L'Oreal
Phase
Observational
Overall status
Completed
Start date
March 27, 2023
Completion date
September 1, 2023
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

visible light exposure on healthy back skin